Clinical Trial Update: The REDUCE EU Study - Endobronchial Thermal Liquid Ablation (ETLA) for the Treatment of Emphysema [NA]

View source ↗

Summary

Clinical trial update for the REDUCE EU study evaluating Endobronchial Thermal Liquid Ablation (ETLA) for emphysema; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Emphysema

Snippet

Sponsor: Morair Medtech, LLC | Conditions: Emphysema or COPD, Emphysema | NA | Status: RECRUITING